Barrington, RI, United States of America

Douglas C Moore

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Douglas C Moore: Innovator in Medical Technology

Introduction

Douglas C Moore is a distinguished inventor based in Barrington, Rhode Island. He has made significant contributions to the field of medical technology, particularly in the areas of gastrointestinal health and bone regeneration. With a total of three patents to his name, Moore's work has the potential to impact patient care and treatment methodologies.

Latest Patents

One of Moore's latest patents is a marker for gastrointestinal tumors. This invention identifies OSTERIX (also known as SP7) as a marker for gastrointestinal stem cells, which is expressed widely and at elevated levels in human gastrointestinal tumors. Another notable patent is related to methods for the treatment of distraction osteogenesis using PDGF. This invention involves compositions and methods for use in osteodistraction procedures, specifically a method that stimulates osteogenesis during and/or following bone distraction by applying a PDGF solution in a biocompatible matrix.

Career Highlights

Throughout his career, Douglas C Moore has worked with several reputable organizations. He has been associated with Biomimetic Therapeutics, LLC, where he contributed to innovative medical solutions. Additionally, he has worked at Rhode Island Hospital, further enhancing his expertise in the medical field.

Collaborations

Moore has collaborated with notable professionals in his field, including Samuel E Lynch and Charles E Hart. These collaborations have likely enriched his research and development efforts, leading to impactful innovations.

Conclusion

Douglas C Moore is a prominent inventor whose work in medical technology continues to advance the understanding and treatment of gastrointestinal conditions and bone regeneration. His patents reflect a commitment to improving patient outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…